<DOC>
	<DOCNO>NCT00808730</DOCNO>
	<brief_summary>Asthma frequent disease characterize bronchial hyperresponsiveness , inflammation remodelling . Bronchial remodelling abnormal repair process contribute development poorly reversible airway narrow . It appear early evolution disease involve increase mass bronchial smooth muscle ( BSM ) . The mechanism increase related increase smooth muscle cell proliferation . Recently , demonstrate , BSM increase proliferation induce enhanced mitochondrial biogenesis severe asthma ( T. Trian et al . J Exp Med 2007 ) . The objective study investigate role smooth muscle cell mitochondrion non severe asthma</brief_summary>
	<brief_title>Role Mitochondria Non Severe Asthma</brief_title>
	<detailed_description>Bronchial remodelling mainly involve increased mass bronchial smooth muscle ( BSM ) , related increase proliferation BSM cell . Recently , use BSM cell obtain severe asthmatic , demonstrate increase proliferation induce activation cascade involve abnormal calcium entry , subsequent activation Calmodulin-kinase IV , PGC-1alpha , NRF-1 mt-TFA lead increase mitochondrial biogenesis ( T. Trian et al , J Exp Med 2007 ) . The objective study investigate role BSM cell mitochondrion non severe asthma . For purpose , 30 non severe asthmatic adult patient ( &gt; 18 yr ) prospectively recruit `` CHU de Bordeaux '' accord Global Initiative Asthma ( GINA ) guideline . Inclusion visit include write informed consent , asthma control questionnaire , clinical examination , lung function test ( i.e . arterial gas , exhale NO , plethysmography ) , prick test , chest X Ray blood sample total IgE level . Bronchial specimen obtain subject fiberoptic bronchoscopy . BSM remodelling evaluated morphological analysis . Patients divide 2 group accord presence absence BSM remodelling . Using BSM cell culture , role mitochondrion analyze electronic microscopy , confocal microscopy , immunoblotting , RT-PCR oxygraphy .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Male female age 18 year Diagnosis intermittent asthma , mild persistent asthma moderate persistent accord ATS criterion Forced expiratory volume one second &gt; 60 % predict Written inform consent Smoker former smoker ( tobacco cannabis ) Adults protect law Subjects affiliate social security Subjects exclusion relative another protocol annual maximum allowance 3800 euro reach Subject comorbidity ( except chronic rhinitis , chronic sinusitis nasal polyp gastrooesophageal reflux ) Asthma exacerbation within 6 week enrolment Infections upper airway within 3 month enrolment Chronic viral infection ( hepatitis , HIV ) Pregnancy breastfeed Contraindications bronchoscopy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Asthma , airway remodelling , smooth muscle , mitochondrion</keyword>
</DOC>